↓ Skip to main content

Risks to the community pharmacists and pharmacy personnel during COVID-19 pandemic: perspectives from a low-income country

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, July 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
143 Mendeley
Title
Risks to the community pharmacists and pharmacy personnel during COVID-19 pandemic: perspectives from a low-income country
Published in
Journal of Pharmaceutical Policy and Practice, July 2020
DOI 10.1186/s40545-020-00250-2
Pubmed ID
Authors

B. Dzingirai, C. M. J. Matyanga, T. Mudzviti, M. Siyawamwaya, D. Tagwireyi

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 143 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 143 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 26 18%
Student > Master 17 12%
Other 10 7%
Lecturer 9 6%
Researcher 7 5%
Other 23 16%
Unknown 51 36%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 30 21%
Medicine and Dentistry 24 17%
Nursing and Health Professions 8 6%
Biochemistry, Genetics and Molecular Biology 5 3%
Social Sciences 5 3%
Other 18 13%
Unknown 53 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2020.
All research outputs
#5,173,611
of 25,380,192 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#147
of 500 outputs
Outputs of similar age
#114,120
of 404,137 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#8
of 26 outputs
Altmetric has tracked 25,380,192 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 500 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.0. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 404,137 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.